Risk Adapted Free Flattering Filter Based Stereotactic Ablative Radiotherapy (Sabr) in Stage i Nsclc and Lung Metastases
The intervention (dose and fractions) depends on topographical parameters: lung disease
(primary, peripheral nodes or mediastinal nodes), distance to chest wall, tumour size and
distance to main bronchus.
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
probability of not suffering a grade 3 or higher toxicity
Patients will be follow-up during one year. If patient suffered any toxicity grade 3 or higher during this period it will be classified as having toxicity. Otherwise patient will be classified as not having toxicity.
Arturo Navarro-Martin, md
Institut Català d'Oncologia - L'Hospitalet
Spain: Ethics Committee